Compare $LSTA vs $MBRX | Chartloom

Compare

$LSTA vs $MBRX

Lisata Therapeutics Inc · Moleculin Biotech Inc

LSTA

Lisata Therapeutics Inc

MBRX

Moleculin Biotech Inc

Compare $LSTA vs $MBRX

Comparing Lisata Therapeutics Inc and Moleculin Biotech Inc

LSTALisata Therapeutics Inc

MBRXMoleculin Biotech Inc

LSTALisata Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-90.7%

YTD performance

-45.9%

52W performance

-58.1%

FCF yield

-127.6%

MBRXMoleculin Biotech Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.8%

52W performance

-96.5%

FCF yield

-811.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LSTA

MBRX

Detailed metrics comparison

LSTA

Lisata Therapeutics Inc

MBRX

Moleculin Biotech Inc

Market Cap

LSTA$10M

MBRX$3M

Enterprise Value

LSTA$-786K

MBRX$-4M

Price

LSTA$1.06

MBRX$0.44

P/E Ratio

LSTAN/A

MBRXN/A

P/S Ratio

LSTA96.57x

MBRX0.00x

EV/Sales

LSTA-7.86x

MBRX0.00x

EV/EBITDA

LSTA0.00x

MBRX0.00x

P/B Ratio

LSTA1.61x

MBRX0.86x

P/FCF Ratio

LSTAN/A

MBRXN/A

EV/FCF

LSTA0.06x

MBRX0.16x

PEG Ratio

LSTAN/A

MBRXN/A

Forward P/E (NTM)

LSTAN/A

MBRXN/A

Forward P/S (NTM)

LSTAN/A

MBRXN/A

Revenue (TTM)

LSTA$100K

MBRX$0

Revenue Growth (YoY)

LSTA-90.7%

MBRXN/A

Forward Rev Growth

LSTA44.0%

MBRX131.1%

Gross Margin (TTM)

LSTA9.5%

MBRX0.0%

Operating Margin (TTM)

LSTA0.0%

MBRX0.0%

EBITDA Margin (TTM)

LSTA-11423.0%

MBRX0.0%

Net Margin (TTM)

LSTA-10132.0%

MBRX0.0%

FCF Margin (TTM)

LSTA-12323.0%

MBRXN/A

Net Income (TTM)

LSTA$-10M

MBRX$-33M

FCF (TTM)

LSTA$-12M

MBRX$-25M

EPS (TTM)

LSTA-$1.11

MBRX-$5.73

ROE (TTM)

LSTA-7510.0%

MBRX-3539.0%

ROA (TTM)

LSTA-6015.0%

MBRX-13955.0%

ROIC (TTM)

LSTA-7510.0%

MBRX-3539.0%

Cash

LSTA$10M

MBRX$7M

Debt

LSTA$0

MBRX$0

Net Cash/Debt

LSTA$10M

MBRX$7M

Current Ratio (TTM)

LSTA3.69x

MBRX0.94x

Quick Ratio (TTM)

LSTA3.50x

MBRX0.78x

Debt/Equity (TTM)

LSTA0.00x

MBRX0.00x

Debt/Assets (TTM)

LSTA0.0%

MBRX0.0%

Interest Coverage (TTM)

LSTAN/A

MBRXN/A

Net Debt/EBITDA (TTM)

LSTA0.00x

MBRX0.00x

Beta

LSTA0.97

MBRX2.10

52W Performance

LSTA-58.1%

MBRX-96.5%

YTD Performance

LSTA-45.9%

MBRX-87.8%

% from 52W High

LSTA-79.1%

MBRX-97.2%

% from 52W Low

LSTA7.3%

MBRX173.9%

Asset Turnover (TTM)

LSTA0.01x

MBRX0.00x

FCF Yield (TTM)

LSTA-127.6%

MBRX-811.4%

Earnings Yield (TTM)

LSTA-104.9%

MBRX-1040.8%

Dividend Yield (TTM)

LSTAN/A

MBRXN/A

Rule of 40

LSTA-12,413.7

MBRX0.0

EV/GP/RG

LSTAN/A

MBRXN/A

Ticker research

View LSTA research View MBRX research

Metric	LSTA Lisata Therapeutics Inc	MBRX Moleculin Biotech Inc
Market & Valuation
Market Cap	$10M	$3M
Enterprise Value	$-786K	$-4M
Price	$1.06	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	96.57x	0.00x
EV/Sales	-7.86x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.61x	0.86x
P/FCF Ratio	N/A	N/A
EV/FCF	0.06x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-90.7%	N/A
Forward Rev Growth	44.0%	131.1%
Profitability
Gross Margin (TTM)	9.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11423.0%	0.0%
Net Margin (TTM)	-10132.0%	0.0%
FCF Margin (TTM)	-12323.0%	N/A
Net Income (TTM)	$-10M	$-33M
FCF (TTM)	$-12M	$-25M
EPS (TTM)	-$1.11	-$5.73
ROE (TTM)	-7510.0%	-3539.0%
ROA (TTM)	-6015.0%	-13955.0%
ROIC (TTM)	-7510.0%	-3539.0%
Financial Health
Cash	$10M	$7M
Debt	$0	$0
Net Cash/Debt	$10M	$7M
Current Ratio (TTM)	3.69x	0.94x
Quick Ratio (TTM)	3.50x	0.78x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	2.10
52W Performance	-58.1%	-96.5%
YTD Performance	-45.9%	-87.8%
% from 52W High	-79.1%	-97.2%
% from 52W Low	7.3%	173.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-127.6%	-811.4%
Earnings Yield (TTM)	-104.9%	-1040.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-12,413.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LSTA research	View MBRX research

Valuation

P/S Ratio

MBRX

0.00x

LSTA

96.57x

EV/FCF

LSTA

0.06x

MBRX

0.16x

Growth & revenue

Revenue Growth TTM

LSTA

-90.7%

Forward Revenue Growth

MBRX

131.1%

LSTA

44.0%

Profitability & performance

Gross Margin

LSTA

9.5%

MBRX

0.0%

ROE

MBRX

-3539.0%

LSTA

-7510.0%

FCF Yield %

LSTA

-127.6%

MBRX

-811.4%

52-Week Performance

LSTA

-58.1%

MBRX

-96.5%

Detailed metrics comparison

LSTA

Lisata Therapeutics Inc

MBRX

Moleculin Biotech Inc

Market Cap

LSTA$10M

MBRX$3M

Enterprise Value

LSTA$-786K

MBRX$-4M

Price

LSTA$1.06

MBRX$0.44

P/E Ratio

LSTAN/A

MBRXN/A

P/S Ratio

LSTA96.57x

MBRX0.00x

EV/Sales

LSTA-7.86x

MBRX0.00x

EV/EBITDA

LSTA0.00x

MBRX0.00x

P/B Ratio

LSTA1.61x

MBRX0.86x

P/FCF Ratio

LSTAN/A

MBRXN/A

EV/FCF

LSTA0.06x

MBRX0.16x

PEG Ratio

LSTAN/A

MBRXN/A

Forward P/E (NTM)

LSTAN/A

MBRXN/A

Forward P/S (NTM)

LSTAN/A

MBRXN/A

Revenue (TTM)

LSTA$100K

MBRX$0

Revenue Growth (YoY)

LSTA-90.7%

MBRXN/A

Forward Rev Growth

LSTA44.0%

MBRX131.1%

Gross Margin (TTM)

LSTA9.5%

MBRX0.0%

Operating Margin (TTM)

LSTA0.0%

MBRX0.0%

EBITDA Margin (TTM)

LSTA-11423.0%

MBRX0.0%

Net Margin (TTM)

LSTA-10132.0%

MBRX0.0%

FCF Margin (TTM)

LSTA-12323.0%

MBRXN/A

Net Income (TTM)

LSTA$-10M

MBRX$-33M

FCF (TTM)

LSTA$-12M

MBRX$-25M

EPS (TTM)

LSTA-$1.11

MBRX-$5.73

ROE (TTM)

LSTA-7510.0%

MBRX-3539.0%

ROA (TTM)

LSTA-6015.0%

MBRX-13955.0%

ROIC (TTM)

LSTA-7510.0%

MBRX-3539.0%

Cash

LSTA$10M

MBRX$7M

Debt

LSTA$0

MBRX$0

Net Cash/Debt

LSTA$10M

MBRX$7M

Current Ratio (TTM)

LSTA3.69x

MBRX0.94x

Quick Ratio (TTM)

LSTA3.50x

MBRX0.78x

Debt/Equity (TTM)

LSTA0.00x

MBRX0.00x

Debt/Assets (TTM)

LSTA0.0%

MBRX0.0%

Interest Coverage (TTM)

LSTAN/A

MBRXN/A

Net Debt/EBITDA (TTM)

LSTA0.00x

MBRX0.00x

Beta

LSTA0.97

MBRX2.10

52W Performance

LSTA-58.1%

MBRX-96.5%

YTD Performance

LSTA-45.9%

MBRX-87.8%

% from 52W High

LSTA-79.1%

MBRX-97.2%

% from 52W Low

LSTA7.3%

MBRX173.9%

Asset Turnover (TTM)

LSTA0.01x

MBRX0.00x

FCF Yield (TTM)

LSTA-127.6%

MBRX-811.4%

Earnings Yield (TTM)

LSTA-104.9%

MBRX-1040.8%

Dividend Yield (TTM)

LSTAN/A

MBRXN/A

Rule of 40

LSTA-12,413.7

MBRX0.0

EV/GP/RG

LSTAN/A

MBRXN/A

Ticker research

View LSTA research View MBRX research

Metric	LSTA Lisata Therapeutics Inc	MBRX Moleculin Biotech Inc
Market & Valuation
Market Cap	$10M	$3M
Enterprise Value	$-786K	$-4M
Price	$1.06	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	96.57x	0.00x
EV/Sales	-7.86x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.61x	0.86x
P/FCF Ratio	N/A	N/A
EV/FCF	0.06x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-90.7%	N/A
Forward Rev Growth	44.0%	131.1%
Profitability
Gross Margin (TTM)	9.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11423.0%	0.0%
Net Margin (TTM)	-10132.0%	0.0%
FCF Margin (TTM)	-12323.0%	N/A
Net Income (TTM)	$-10M	$-33M
FCF (TTM)	$-12M	$-25M
EPS (TTM)	-$1.11	-$5.73
ROE (TTM)	-7510.0%	-3539.0%
ROA (TTM)	-6015.0%	-13955.0%
ROIC (TTM)	-7510.0%	-3539.0%
Financial Health
Cash	$10M	$7M
Debt	$0	$0
Net Cash/Debt	$10M	$7M
Current Ratio (TTM)	3.69x	0.94x
Quick Ratio (TTM)	3.50x	0.78x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	2.10
52W Performance	-58.1%	-96.5%
YTD Performance	-45.9%	-87.8%
% from 52W High	-79.1%	-97.2%
% from 52W Low	7.3%	173.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-127.6%	-811.4%
Earnings Yield (TTM)	-104.9%	-1040.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-12,413.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LSTA research	View MBRX research